?:authorAffiliation
|
-
[\'Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.\', \'Department of Medicine, Surgery and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy; U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale, Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy.\', \'U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale, Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy.\', \'Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.\', \'Department of Management, University of Turin, Turin, Italy; Centre for Research on Health and Social Care Management (CeRGAS), SDA Bocconi School of Management, Milan, Italy.\', \'Division of Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.\', \'Scientific Direction, IEO, European Institute of Oncology IRCCS, Milan, Italy.\', \'Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.\']
|